0.2504
price down icon3.73%   -0.0096
 
loading
전일 마감가:
$0.26
열려 있는:
$0.2504
하루 거래량:
1.14M
Relative Volume:
0.09
시가총액:
$36.13M
수익:
-
순이익/손실:
$-119.76M
주가수익비율:
-0.1855
EPS:
-1.35
순현금흐름:
$-55.17M
1주 성능:
-3.10%
1개월 성능:
-78.23%
6개월 성능:
-29.15%
1년 성능:
-87.67%
1일 변동 폭
Value
$0.2459
$0.2573
1주일 범위
Value
$0.238
$0.266
52주 변동 폭
Value
$0.2182
$2.09

Applied Therapeutics Inc Stock (APLT) Company Profile

Name
명칭
Applied Therapeutics Inc
Name
전화
212-220-9226
Name
주소
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Name
직원
28
Name
트위터
@Applied_Tx
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
APLT's Discussions on Twitter

APLT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
APLT
Applied Therapeutics Inc
0.2504 37.52M 0 -119.76M -55.17M -1.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.64 110.02B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
766.04 82.00B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
459.25 59.61B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
890.01 56.15B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
207.74 44.31B 447.02M -1.18B -906.14M -6.1812

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-23 다운그레이드 William Blair Outperform → Mkt Perform
2024-12-02 다운그레이드 UBS Buy → Neutral
2024-11-29 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-07-31 개시 William Blair Outperform
2024-03-26 개시 RBC Capital Mkts Outperform
2024-02-22 개시 Leerink Partners Outperform
2022-01-04 다운그레이드 Barclays Overweight → Equal Weight
2021-08-27 다운그레이드 Goldman Neutral → Sell
2021-06-25 재개 Goldman Neutral
2020-10-08 개시 Truist Buy
2020-04-22 개시 Goldman Buy
2020-02-27 개시 Barclays Overweight
2019-06-10 개시 Citigroup Buy
2019-06-10 개시 Cowen Outperform
2019-06-10 개시 Robert W. Baird Outperform
모두보기

Applied Therapeutics Inc 주식(APLT)의 최신 뉴스

pulisher
Nov 30, 2025

What analysts say about Applied Therapeutics Inc stockHead and Shoulders Patterns & Minimal Investment Trading - earlytimes.in

Nov 30, 2025
pulisher
Nov 27, 2025

Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - Yahoo Finance

Nov 27, 2025
pulisher
Nov 27, 2025

Applied Therapeutics Reports Third Quarter 2025 Financial Results - ADVFN

Nov 27, 2025
pulisher
Nov 23, 2025

Applied Therapeutics To Lay Off Nearly Half Its Staff, Board Explores M&A Options - MSN

Nov 23, 2025
pulisher
Nov 21, 2025

Applied Therapeutics (APLT) Stock Price, Quote, News & History - Benzinga

Nov 21, 2025
pulisher
Nov 21, 2025

Applied Therapeutics Investors Get 1st OK For $15M Deal - Law360

Nov 21, 2025
pulisher
Nov 21, 2025

Why Applied Therapeutics Inc. stock could see breakout soonMarket Trend Review & Weekly Momentum Stock Picks - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Applied Therapeutics explores strategic alternatives amid workforce cuts By Investing.com - Investing.com Nigeria

Nov 20, 2025
pulisher
Nov 20, 2025

Applied Therapeutics Announces Corporate Updates - Investing News Network

Nov 20, 2025
pulisher
Nov 20, 2025

Applied Therapeutics, Inc. Initiates Strategic Alternatives Review - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

Applied Therapeutics explores strategic alternatives amid workforce cuts - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

APLT Evaluates Strategic Options as Workforce Reductions Announced - GuruFocus

Nov 20, 2025
pulisher
Nov 20, 2025

APLT Evaluates FDA Meeting Outcomes for Govorestat Development P - GuruFocus

Nov 20, 2025
pulisher
Nov 20, 2025

What data driven models say about Applied Therapeutics Inc.’s future - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Applied Therapeutics (Nasdaq: APLT) to Explore Strategic Alternatives, Reduce Workforce 46% - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Can Applied Therapeutics Inc. (2UV) stock surprise markets with earningsMarket Volume Report & High Win Rate Trade Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Applied Therapeutics Inc. (2UV) stock prepared for digital transitionMarket Sentiment Review & Growth Focused Stock Pick Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Applied Therapeutics Inc. stock reacts to inflationary pressuresWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can Applied Therapeutics Inc. (2UV) stock expand revenue streamsJuly 2025 Breakouts & Safe Swing Trade Setups - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Applied Therapeutics Inc. (2UV) stock a top pick for value investorsEarnings Risk Report & Detailed Earnings Play Strategies - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why Applied Therapeutics Inc. (2UV) stock fits value portfoliosVolume Spike & Free Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Applied Therapeutics Inc. stock daily chart insightsJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Does Applied Therapeutics Inc. show high probability of reboundJuly 2025 Earnings & Smart Investment Allocation Insights - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Statistical indicators supporting Applied Therapeutics Inc.’s strengthPortfolio Update Report & Low Drawdown Investment Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Analyzing Applied Therapeutics Inc. with multi timeframe chartsEarnings Summary Report & Fast Moving Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 00:29:12 - newser.com

Nov 19, 2025

Applied Therapeutics Inc (APLT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Applied Therapeutics Inc 주식 (APLT) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Funtleyder Leslie D.
See Remarks
Mar 04 '25
Sale
0.44
14,502
6,381
390,459
Chinoporos Constantine
See Remarks
Mar 04 '25
Sale
0.44
447
197
271,436
Funtleyder Leslie D.
See Remarks
Feb 06 '25
Sale
0.61
22,950
14,000
404,961
Perfetti Riccardo
Chief Medical Officer
Feb 06 '25
Sale
0.61
86,078
52,508
900,775
Chinoporos Constantine
See Remarks
Feb 06 '25
Sale
0.61
28,117
17,151
271,883
$39.83
price down icon 0.25%
$102.35
price down icon 2.13%
$31.82
price down icon 1.70%
$99.47
price down icon 3.64%
biotechnology ONC
$335.97
price down icon 1.32%
$207.05
price down icon 0.39%
자본화:     |  볼륨(24시간):